Literature DB >> 11737079

Differential roles of osteopontin/Eta-1 in early and late lpr disease.

G F Weber1, H Cantor.   

Abstract

The cytokine osteopontin (Eta-1) leads to macrophage-dependent polyclonal B-cell activation and is induced early in autoimmune prone mice with the lpr mutation, suggesting a significant pathogenic role for this molecule. Indeed, C57BL/6-Fas(lpr/lpr) mice crossed with osteopontin(-/-) mice display delayed onset of polyclonal B-cell activation, as judged by serum immunoglobulin levels. In contrast, they are subject to normal onset, but late exacerbation of lymphoproliferation and evidence of kidney disease. These observations define two stages of Fas(lpr/lpr) disease with respect to osteopontin-dependent pathogenesis that should be taken into account in the design of therapeutic approaches to the clinical disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737079      PMCID: PMC1906233          DOI: 10.1046/j.1365-2249.2001.01702.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Detection of circulating immune complexes in MRL mice with different forms of glomerulonephritis.

Authors:  M Hewicker; E Kromschröder; G Trautwein
Journal:  Z Versuchstierkd       Date:  1990

2.  Age-dependent isotype variation during secondary immune response in MRL/lpr mice producing autoanti-gamma-globulin antibodies.

Authors:  A Manheimer; C Bona
Journal:  Eur J Immunol       Date:  1985-07       Impact factor: 5.532

3.  Renal lesions in MRL mice.

Authors:  G J Kolaja; P E Fast
Journal:  Vet Pathol       Date:  1982-11       Impact factor: 2.221

4.  Induction of various autoantibodies by mutant gene lpr in several strains of mice.

Authors:  S Izui; V E Kelley; K Masuda; H Yoshida; J B Roths; E D Murphy
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

5.  Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice.

Authors:  F Zavala; A Masson; K Hadaya; S Ezine; E Schneider; O Babin; J F Bach
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

6.  Interaction of mutant lpr gene with background strain influences renal disease.

Authors:  V E Kelley; J B Roths
Journal:  Clin Immunol Immunopathol       Date:  1985-11

7.  CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.

Authors:  J D Mountz; H R Smith; R L Wilder; J P Reeves; A D Steinberg
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

8.  Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice.

Authors:  G H Tesch; S Maifert; A Schwarting; B J Rollins; V R Kelley
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

9.  Dysregulated expression of the T cell cytokine Eta-1 in CD4-8- lymphocytes during the development of murine autoimmune disease.

Authors:  R Patarca; F Y Wei; P Singh; M I Morasso; H Cantor
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  Determinants recognized by murine rheumatoid factors: molecular localization using a panel of mouse myeloma variant immunoglobulins.

Authors:  V Stassin; P G Coulie; B K Birshtein; D S Secher; J Van Snick
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin.

Authors:  T L Rothstein; B Guo
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

2.  T-bet-dependent expression of osteopontin contributes to T cell polarization.

Authors:  Mari L Shinohara; Marianne Jansson; Eun Sook Hwang; Miriam B F Werneck; Laurie H Glimcher; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

Review 3.  Osteopontin in autoimmune disorders: current knowledge and future perspective.

Authors:  Canhua Xu; Yaohong Wu; Ning Liu
Journal:  Inflammopharmacology       Date:  2022-03-02       Impact factor: 5.093

4.  B cell receptor crosstalk: B cells express osteopontin through the combined action of the alternate and classical BCR signaling pathways.

Authors:  Benchang Guo; Joseph R Tumang; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2008-10-25       Impact factor: 4.407

5.  Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.

Authors:  J D Coombes; M Swiderska-Syn; L Dollé; D Reid; B Eksteen; L Claridge; M A Briones-Orta; S Shetty; Y H Oo; A Riva; S Chokshi; S Papa; Z Mi; P C Kuo; R Williams; A Canbay; D H Adams; A M Diehl; L A van Grunsven; S S Choi; W K Syn
Journal:  Gut       Date:  2014-06-05       Impact factor: 23.059

6.  Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.

Authors:  Jessica S Kim; Muhammad M Bashir; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2012-03-29       Impact factor: 8.551

7.  Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.

Authors:  Jason D Coombes; Steve S Choi; Marzena Swiderska-Syn; Paul Manka; Danielle T Reid; Elena Palma; Marco A Briones-Orta; Guanhua Xie; Rasha Younis; Naoto Kitamura; Marco Della Peruta; Shanna Bitencourt; Laurent Dollé; Ye Htun Oo; Zhiyong Mi; Paul C Kuo; Roger Williams; Shilpa Chokshi; Ali Canbay; Lee C Claridge; Bertus Eksteen; Anna Mae Diehl; Wing-Kin Syn
Journal:  Biochim Biophys Acta       Date:  2015-10-31

8.  Elevated osteopontin levels in mild cognitive impairment and Alzheimer's disease.

Authors:  Yuan Sun; Xue Song Yin; Hong Guo; Rong Kun Han; Rui Dong He; Li Jun Chi
Journal:  Mediators Inflamm       Date:  2013-03-14       Impact factor: 4.711

9.  Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and CD4+ T cell-related gene responses in the autoimmune NZBWF1 mouse.

Authors:  James J Pestka; Laura L Vines; Melissa A Bates; Kaiyu He; Ingeborg Langohr
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

Review 10.  Role of osteopontin in systemic lupus erythematosus.

Authors:  Beata Kaleta
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-06-11       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.